Methotrexate treatment of very high β-HCG ectopic pregnancy on previous cesarean scar: A case report.
Cesarean scar pregnancy
Conservative management
Ectopic pregnancy
Methotrexate treatment
Journal
Radiology case reports
ISSN: 1930-0433
Titre abrégé: Radiol Case Rep
Pays: Netherlands
ID NLM: 101467888
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
01
06
2023
revised:
03
08
2023
accepted:
08
08
2023
medline:
18
9
2023
pubmed:
18
9
2023
entrez:
18
9
2023
Statut:
epublish
Résumé
Ectopic pregnancy in a previous caesarean scar is a rare, potentially life-threatening situation that can cause massive bleeding and uterine rupture. Clinical symptoms can range from vaginal bleeding with or without pain, to uterine rupture with hypovolemic shock. Early diagnosis is possible by ultrasound examination, and it is very important because it leads to prompt management, improving maternal morbidity and mortality as well as future fertility. The current case report refers to a G3P2 woman with a history of 2 previous caesarean deliveries, who was diagnosed with an ectopic pregnancy on the caesarean scar using ultrasonography. The patient was treated with methotrexate both systemic and into the sac, as well as with injection into the sac of 5mEq potassium chloride. The woman was followed up until measurements of serum β-Human Chorionic Gonadotropin were within nonpregnant levels. There is no clear-cut best way to handle cesarean scar pregnancy. Pregnancy with a cesarean scar should be identified and treated as soon as possible in order to avoid serious problems and preserve fertility. However, even more advanced cesarean scar pregnancies can be managed conservatively at first, when a highly expertized team in a tertiary hospital is available.
Identifiants
pubmed: 37720917
doi: 10.1016/j.radcr.2023.08.051
pii: S1930-0433(23)00572-1
pmc: PMC10504459
doi:
Types de publication
Case Reports
Langues
eng
Pagination
4106-4109Informations de copyright
© 2023 The Authors. Published by Elsevier Inc. on behalf of University of Washington.
Références
J Reprod Med. 2000 Sep;45(9):754-7
pubmed: 11027086
J Postgrad Med. 2022 Jan-Mar;68(1):35-37
pubmed: 35073684
J Ultrason. 2018 Mar;18(72):56-62
pubmed: 29844942
Am J Obstet Gynecol. 2012 Jul;207(1):44.e1-13
pubmed: 22607667
Hum Reprod Open. 2021 May 01;2021(2):hoab019
pubmed: 33959686
Fertil Steril. 1989 Feb;51(2):354-6
pubmed: 2912784
Ginekol Pol. 2018;89(4):195-9
pubmed: 29781074
Gynecol Endocrinol. 2019 Apr;35(4):337-341
pubmed: 30430877
BJOG. 2007 Mar;114(3):253-63
pubmed: 17313383
Fertil Steril. 2010 Apr;93(6):1735-40
pubmed: 19342043
Obstet Gynecol. 1998 May;91(5 Pt 2):838-40
pubmed: 9572183
Ultrasound Obstet Gynecol. 2000 Nov;16(6):592-3
pubmed: 11169360
J Minim Invasive Gynecol. 2019 Jul - Aug;26(5):919-927
pubmed: 30243684
Ultrasound Obstet Gynecol. 2003 Mar;21(3):220-7
pubmed: 12666214
J Med Case Rep. 2021 Oct 9;15(1):506
pubmed: 34625100
Int J Clin Exp Med. 2015 Oct 15;8(10):18972-80
pubmed: 26770522
Case Rep Obstet Gynecol. 2021 Feb 9;2021:8888019
pubmed: 33628549